Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

ANKYLOS C/X Implant B6.6: medical device reports filed with FDA

1,376 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

1,376
device reports naming the brand
0% of all MAUDE reports · about 194 a year
188
reports, 12 months to August 2026
164 in the 12 months before
0.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,376 reports that name the brand "ANKYLOS C/X Implant B6.6" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

188 reports arrived in the 12 months to August 2026, up 15% from 164 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (46.4%), osseointegration problem (26.9%) and loss of osseointegration (26%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02142Sep 2021: 20Oct 2021: 5Nov 2021: 16Dec 2021: 222022Jan 2022: 32Feb 2022: 14Mar 2022: 27Apr 2022: 31May 2022: 34Jun 2022: 38Jul 2022: 16Aug 2022: 12Sep 2022: 27Oct 2022: 16Nov 2022: 28Dec 2022: 172023Jan 2023: 17Feb 2023: 17Mar 2023: 18Apr 2023: 42May 2023: 11Jun 2023: 21Jul 2023: 14Aug 2023: 22Sep 2023: 20Oct 2023: 21Nov 2023: 23Dec 2023: 112024Jan 2024: 22Feb 2024: 29Mar 2024: 27Apr 2024: 16May 2024: 21Jun 2024: 20Jul 2024: 16Aug 2024: 22Sep 2024: 10Oct 2024: 10Nov 2024: 14Dec 2024: 92025Jan 2025: 15Feb 2025: 13Mar 2025: 26Apr 2025: 6May 2025: 11Jun 2025: 11Jul 2025: 27Aug 2025: 12Sep 2025: 19Oct 2025: 14Nov 2025: 13Dec 2025: 152026Jan 2026: 16Feb 2026: 30Mar 2026: 19Apr 2026: 13May 2026: 10Jun 2026: 13Jul 2026: 19Aug 2026: 7

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01462922019: 3420192021: 28820212022: 29220222023: 23720232024: 21620242025: 18220252026: 1272026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.9%1,375
Malfunction0.1%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,376
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate63846.4%62.8%
Osseointegration problem37026.9%7.7%
Loss of osseointegration35826%22.4%
Separation failure30.2%0.1%
Damaged thread20.1%0%
Fracturea broken bone20.1%1.6%
Loosening of implant not related to bone-ingrowth20.1%0.1%
Difficult to insertthe device was hard to insert10.1%0.4%
Fluid/blood leak10.1%0%
Malposition of device10.1%0.1%
Migration or expulsion of device10.1%0%
Off-label use10.1%0%
Patient-device incompatibilitythe device did not suit the patient10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,37499.9%
Inflammationinflammation1027.4%
Pocket erosion956.9%
Osteolysis775.6%
Implant pain60.4%
Painpain, site not specified20.1%
Osteomyelitis10.1%
Sinus perforation10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureANKYLOS C/X Implant B6.6Product code DZEAll MAUDE reports
Reports1,3763,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury99.9%99.2%36.2%
Classified as malfunction0.1%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about ANKYLOS C/X Implant B6.6 reports

How many FDA reports name ANKYLOS C/X Implant B6.6?

1,376 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 188 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and malfunction (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (46.4%), osseointegration problem (26.9%), loss of osseointegration (26%), separation failure (0.2%) and damaged thread (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that ANKYLOS C/X Implant B6.6 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.